ex vivo method for testing whether a patient will respond therapeutically to a method of treatment, use of activated natural killer cell levels as a biomarker, and

• 收藏
• 分享

专利权人:

Trangène S.A.

发明人:

Bruce Acres,Bérangère Marie-Bastien

申请号：

BRPI0913108

公开号：

BRPI0913108A2

申请日:

2009.05.27

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The present invention concerns methods for inducing an immune response to an antigen in a patient for treating human disease by administering an immunogenic composition wherein said patient is selected in a patient population of interest. The present invention further concerns methods for determining whether a subject is or is not susceptible to developing a prophylactic or therapeutic immune response after such treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/